Skip to main content
SpringerLink
Log in

Future Directions

  • Chapter
  • First Online:
Hyperlipidemia Management for Primary Care

  • 639 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of Cholesterol Lowering in 20,536 high-risk individuals: a randomized placebo controlled trial. Lancet 2002;360:7–22.

    Google Scholar 

  2. Pedersen TR, Faergeman O, Kastelein JJP, et al. High-dose atorvastatin vs. usual-dose simvastatin for secondary prevention after myocardial infarction. IDEAL study: a randomized controlled trial. JAMA 2005;294:2437–2445.

    Article  PubMed  CAS  Google Scholar 

  3. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA). Lancet 2003;361:1149–1158.

    Article  PubMed  CAS  Google Scholar 

  4. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425–1435.

    Article  PubMed  CAS  Google Scholar 

  5. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495–1504.

    Article  PubMed  CAS  Google Scholar 

  6. Cannon CP, Steinberg BA, Murphy SA, et al. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48:438–445.

    Article  PubMed  CAS  Google Scholar 

  7. Cuchel M, Bloedon LT, Szapary PO, et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med 2007;356:148–156.

    Article  PubMed  CAS  Google Scholar 

  8. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419–1423.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chair and Associate Professor, Department of Family Medicine, Uniformed Services, University of the Health Sciences, Bethesda, Maryland

    Brian V. Reamy

Authors
  1. Brian V. Reamy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian V. Reamy .

Editor information

Editors and Affiliations

  1. Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    Brian V. Reamy MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Reamy, B.V. (2008). Future Directions. In: Reamy, B.V. (eds) Hyperlipidemia Management for Primary Care. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76606-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-76606-5_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-76605-8

  • Online ISBN: 978-0-387-76606-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation